D I Chu1, K Gupta2, T Kawal3, J P Van Batavia3, D K Bowen3, M R Zaontz3, T F Kolon3, D A Weiss3, S A Zderic3, D A Canning3. 1. Division of Urology, Children's Hospital of Philadelphia, Philadelphia, USA. Electronic address: dchu@luriechildrens.org. 2. The George Washington University School of Medicine and Health Sciences, Washington, USA. 3. Division of Urology, Children's Hospital of Philadelphia, Philadelphia, USA.
Abstract
INTRODUCTION: In testicular torsion, ischemia time from pain onset impacts testicular salvage. A tunica albuginea fasciotomy to relieve compartment pressure followed by a tunica vaginalis flap (TVF) may enhance salvage. OBJECTIVE: To define the optimal window of ischemia time during which TVF may be most beneficial to avoid orchiectomy. STUDY DESIGN: A retrospective cohort study of males presenting with testicular torsion at a single tertiary-care institution from January, 2003 to March, 2017. Ischemia time was defined as duration of pain from onset to surgery. Because TVF would be an option to orchiectomy, and it was found that ischemia time was longer in testicles that underwent orchiectomy, matching was performed. Cases of torsion treated with TVF were matched 1:1 with cases treated with orchiectomy on age at surgery, and ischemia time. Outcomes included postoperative viability, defined as palpable testicular tissue with normal consistency, and atrophy, defined as palpable decrease in size relative to contralateral testicle. Sensitivity analyses were performed restricting to the subgroups with postoperative ultrasound, >6 months' follow-up, and additionally matching for degrees of twist. RESULTS: A total of 182 patients met eligibility criteria, of whom 49, 36, and 97 underwent orchiectomy, TVF, and septopexy alone, respectively. Median follow-up was 2.7 months; 26% of patients had postoperative ultrasound (61% of TVF group). In the orchiectomy, TVF, and septopexy groups, respectively, median ischemia times were 51, 11, and 8 h, postoperative viability rates were 0, 86, and 95%, and postoperative atrophy rates were 0, 68, and 24%. After matching, 32 patients with TVF were matched to 32 patients who underwent orchiectomy. In the TVF group, postoperative viability occurred in 95% (19/20) vs 67% (8/12) of patients with ischemia times ≤24 and >24 h, respectively. Atrophy occurred in 67% (12/18) vs 83% (10/12) of these same respective patients. Sensitivity analysis by ultrasound and longer follow-up found similar viability results, although atrophy rates were higher. Additional matching for degrees of twist showed lower viability and higher atrophy rates for increasing ischemia times. DISCUSSION: Patients who presented with testicular torsion with ischemia times ≤24 h and who were being considered for orchiectomy may have benefitted most from TVF, albeit at high risk of atrophy. However, for ischemia times >24 h, TVF may still have preserved testicular viability in two-thirds of cases. A limitation was short follow-up. CONCLUSION: A TVF was a valid alternative to orchiectomy for torsed testicles, albeit with high testicular atrophy rates.
INTRODUCTION: In testicular torsion, ischemia time from pain onset impacts testicular salvage. A tunica albuginea fasciotomy to relieve compartment pressure followed by a tunica vaginalis flap (TVF) may enhance salvage. OBJECTIVE: To define the optimal window of ischemia time during which TVF may be most beneficial to avoid orchiectomy. STUDY DESIGN: A retrospective cohort study of males presenting with testicular torsion at a single tertiary-care institution from January, 2003 to March, 2017. Ischemia time was defined as duration of pain from onset to surgery. Because TVF would be an option to orchiectomy, and it was found that ischemia time was longer in testicles that underwent orchiectomy, matching was performed. Cases of torsion treated with TVF were matched 1:1 with cases treated with orchiectomy on age at surgery, and ischemia time. Outcomes included postoperative viability, defined as palpable testicular tissue with normal consistency, and atrophy, defined as palpable decrease in size relative to contralateral testicle. Sensitivity analyses were performed restricting to the subgroups with postoperative ultrasound, >6 months' follow-up, and additionally matching for degrees of twist. RESULTS: A total of 182 patients met eligibility criteria, of whom 49, 36, and 97 underwent orchiectomy, TVF, and septopexy alone, respectively. Median follow-up was 2.7 months; 26% of patients had postoperative ultrasound (61% of TVF group). In the orchiectomy, TVF, and septopexy groups, respectively, median ischemia times were 51, 11, and 8 h, postoperative viability rates were 0, 86, and 95%, and postoperative atrophy rates were 0, 68, and 24%. After matching, 32 patients with TVF were matched to 32 patients who underwent orchiectomy. In the TVF group, postoperative viability occurred in 95% (19/20) vs 67% (8/12) of patients with ischemia times ≤24 and >24 h, respectively. Atrophy occurred in 67% (12/18) vs 83% (10/12) of these same respective patients. Sensitivity analysis by ultrasound and longer follow-up found similar viability results, although atrophy rates were higher. Additional matching for degrees of twist showed lower viability and higher atrophy rates for increasing ischemia times. DISCUSSION: Patients who presented with testicular torsion with ischemia times ≤24 h and who were being considered for orchiectomy may have benefitted most from TVF, albeit at high risk of atrophy. However, for ischemia times >24 h, TVF may still have preserved testicular viability in two-thirds of cases. A limitation was short follow-up. CONCLUSION: A TVF was a valid alternative to orchiectomy for torsed testicles, albeit with high testicular atrophy rates.
Authors: Cagatay E Afsarlar; Sheila L Ryan; Edward Donel; Truc H Baccam; Beth Jones; Barkha Chandwani; Jason Au; Gene O Huang; Edmond T Gonzales; Nicolette Janzen; Duong Tu; Abhishek Seth; David R Roth; Chester J Koh Journal: J Pediatr Urol Date: 2016-05-15 Impact factor: 1.830
Authors: G Tryfonas; A Violaki; G Tsikopoulos; P Avtzoglou; J Zioutis; C Limas; G Gregoriadis; M Badouraki Journal: J Pediatr Surg Date: 1994-04 Impact factor: 2.545
Authors: Alexander Kutikov; Pasquale Casale; Michael A White; Wesley A Meyer; Andy Chang; Rafael Gosalbez; Douglas A Canning Journal: Urology Date: 2008-06-17 Impact factor: 2.649
Authors: Victor Figueroa; Joao L Pippi Salle; Luis H P Braga; Rodrigo Romao; Martin A Koyle; Darius J Bägli; Armando J Lorenzo Journal: J Urol Date: 2012-08-17 Impact factor: 7.450
Authors: Marco A Arap; Fabio C Vicentini; Marcello Cocuzza; Jorge Hallak; Kelly Athayde; Antonio M Lucon; Sami Arap; Miguel Srougi Journal: J Androl Date: 2007-02-07
Authors: Paweł Osemlak; Grzegorz Jędrzejewski; Magdalena Woźniak; Paweł Nachulewicz Journal: Medicine (Baltimore) Date: 2021-05-28 Impact factor: 1.889
Authors: Mohammed Elifranji; Tariq Abbas; Bruno Leslie; Santiago Vallasciani; Abderrahman El Kadhi; João Luiz Pippi-Salle Journal: Int Braz J Urol Date: 2022 Jul-Aug Impact factor: 3.050